col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


98 Results       Page 1

 [1] 
Elsevier: Cytokine
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―17 Effect of SARS-CoV-2 and Toxoplasma gondii co-infection on IFN-γ and TNF-α expression and its impact on disease severity Magda S.A. Abdeltawab, Mohamed Fateen, Shimaa Saad El-Din, Riem M. Elmessiery, Osama Mohammady Mohamed, Khaled Marzouk Sadek, et al. (+2)
2 [GO] 2024―Feb―15 Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients Jaime Carrillo-García, Serena Lacerenza, Nadia Hindi, David S. Moura, Gloria Marquina, Daniel Parra Corral, et al. (+10)
3 [GO] 2024―Jan―31 Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection Fabiola Mestriner, Daniely F. Francisco, Ligia C.B. Campos, Ariel E.S. Couto, Thais F.C. Fraga-Silva, Vinicius Flora Dugaich, et al. (+21)
4 [GO] 2024―Jan―25 IL-6 is a predictor and potential therapeutic target for coronavirus disease 2019-related heart failure: A single-center retrospective study Yan Xi, Yu Mao, Wei Zhu, Peng Xi, Feifei Huang, Hongwei Tan, et al. (+2)
5 [GO] 2024―Jan―24 IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: A cross-sectional study Maha O. Hammad, Mahmoud M. Alseoudy, Asmaa M. Borg, Ahmed El-Mesery, Mohamed Elgamal, Dalia A. Abdelghany, Dina Elzeiny
6 [GO] 2024―Jan―19 Changes in markers of inflammation and their correlation with death in patients with COVID-19 in the intensive care unit Andressa de Azambuja Pias Weber, Fernanda Tibolla Viero, Micheli Mainardi Pillat, Thissiane de Lima Gonçalves
7 [GO] 2024―Jan―07 Do chemokine/chemokine receptor axes play paramount parts in trafficking and oriented locomotion of monocytes/macrophages toward the lungs of COVID-19 infected patients? A systematic review Merat Mahmoodi, Fatemeh Mohammadi Henjeroei, Gholamhossein Hassanshahi, Reza Nosratabadi
8 [GO] 2024―Jan―07 Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients Zahra Sefatjoo, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Shahrzad Shoraka, Mahsa Saeedi Niasar, Kaveh Baghaei, et al. (+5)
9 [GO] 2023―Dec―22 Multi-faceted dysregulated immune response for COVID-19 infection explaining clinical heterogeneity Suman K. Paine, Parveena Choudhury, Mahabub Alam, Chandrika Bhattacharyya, Subhasish Pramanik, Devashish Tripathi, et al. (+6)
10 [GO] 2023―Dec―20 Protective effects of IL18-105G > A and IL18-137C > G genetic variants on severity of COVID-19 Mayara Tiemi Enokida Mori, Andréa Name Colado Simão, Tiago Danelli, Sayonara Rangel Oliveira, Pedro Luis Candido de Souza Cassela, Guilherme Lerner Trigo, et al. (+7)
11 [GO] 2023―Dec―05 Impact of IL-6 rs1800795 and IL-17A rs2275913 gene polymorphisms on the COVID-19 prognosis and susceptibility in a sample of Iranian patients Mostafa Khafaei, Reza Asghari, Fariba Zafari, Morteza Sadeghi
12 [GO] 2023―Dec―01 Pyrogenic and inflammatory mediators are produced by polarized M1 and M2 macrophages activated with D-dimer and SARS-CoV-2 spike immune complexes Yun-Jong Park, David Acosta, Mohammad Rubel Hoq, Surender Khurana, Hana Golding, Marina Zaitseva
13 [GO] 2023―Nov―16 Cytokine storm in COVID-19 and malaria: Annals of pro-inflammatory cytokines Tabish Qidwai
14 [GO] 2023―Nov―15 Even one dose of tocilizumab could hinder bad prognosis of cytokines storm in COVID-19 patients Mohamed Abdel-Salam Elgohary, Asmaa Ali, Sumaiah J.Alarfaj, Hesham Shahin, Ashraf Ibrahim Zaki, Eman Medhat Hasan, et al. (+9)
15 [GO] 2023―Sep―13 Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of COVID-19 Fatemeh Azarfar, Bahareh Abbasi, Amir Jalali, Mohammad Hadi Abbasian
16 [GO] 2023―Sep―08 Importance of screening severe COVID-19 patients for IFN-λ1, IL-6 and anti-S1 IgG levels Olcay Buse Kenanoğlu, Aytül Gül, Hüseyin Can, Muhammet Karakavuk, Sedef Erkunt Alak, Gülay Korukluoğlu, et al. (+15)
17 [GO] 2023―Sep―06 The significance of IFITM3 polymorphism in COVID-19 asymptomatic and ICU admission Kurdish patients Peshnyar M.A. Rashid, Gaza F. Salih
18 [GO] 2023―Sep―05 Inflammatory and cytotoxic mediators in COVID-19 patients and in ChAdOx1 nCoV-19 (AZD1222) vaccine recipients Débora Familiar-Macedo, Paulo Vieira Damasco, Victor Edgar Fiestas Solórzano, Joyce Carnevale Rodrigues, Elba Regina Sampaio de Lemos, Flávia Barreto dos Santos, et al. (+3)
19 [GO] 2023―Aug―20 COVID-19 vaccination: Effects of immunodominant peptides of SARS-CoV-2 Arthur Gomes de Andrade, Fernando Cézar Comberlang, Luiz Henrique Agra Cavalcante-Silva, Tatjana Souza Lima Kessen
20 [GO] 2023―Aug―04 Characterization of the inflammatory response to COVID-19 illness in pregnancy Alexandra D. Forrest, Natalie E. Poliektov, Kirk A. Easley, Vasiliki Michopoulos, Meghna Ravi, Narayanaiah Cheedarla, et al. (+6)
21 [GO] 2023―Aug―01 A meta analysis on the utility of Anakinra in severe COVID-19 disease Aliae A.R. Mohamed Hussein, Reem Sayad, Abdelrahman Abdelshafi, Islam Abdelaal Hammam, Ahmed M. Kedwany, Shrouk Alaa-eldein Elkholy, Islam H. Ibrahim
22 [GO] 2023―Jun―26 Emerging aspects of cytokine storm in COVID-19: the role of proinflammatory cytokines and therapeutic prospects Renu Dharra, Anil Kumar Sharma, Sonal Datta
23 [GO] 2023―Jun―08 SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study Mohammad Sadegh Soltani-Zangbar, Mahsa Hajivalili, Danyal Daneshdoust, Sara Ghadir, Golaleh Savari, Mohammadali Zolfaghari, et al. (+9)
24 [GO] 2023―Jun―07 The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect Yousef Rasmi, ladan Jalali, Saliha Khalid, Ameneh Shokati, Poonam Tyagi, Alpaslan Ozturk, Amir Nasimfar
25 [GO] 2023―Jun―02 An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease Niv Samuel Mastboim, Alon Angel, Oded Shaham, Tahel Ilan Ber, Roy Navon, Einav Simon, et al. (+24)
26 [GO] 2023―May―22 Impact of COVID-19 and vaccination on first and second trimester screening results Sedigheh Hantoushzadeh, Sarang Younesi, Mohammad Mahdi Taheri Amin, Pourandokht Saadati, So�h Jamali, Saina Nassiri, et al. (+10)
27 [GO] 2023―Mar―24 Identification of key differentially expressed genes in SARS-CoV-2 using RNA-seq analysis with a systems biology approach Arash Safarzadeh, Bashdar Mahmud Hussen, Mohammad Taheri, Soudeh Ghaforui-Fard, Mohammadreza Hajiesmaeili
28 [GO] 2023―Mar―13 Type I and III interferons are good markers to monitor COVID-19 pathophysiology Dounia Darif, Rajaâ Ejghal, Christophe Desterke, Ahmed Outlioua, Ikram Hammi, Meryem Lemrani, et al. (+4)
29 [GO] 2023―Feb―16 T-cell lymphocytopenia: an omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections Jeffrey S. Putter, Jerard Seghatchian
30 [GO] 2022―Dec―14 Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia Charilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, Eran Reiner, Maria Kosmidou, Ioanna Karanika, et al. (+40)
31 [GO] 2022―Dec―13 Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection Leon Cords, Robin Woost, Silke Kummer, Thomas T. Brehm, Stefan Kluge, Stefan Schmiedel, et al. (+6)
32 [GO] 2022―Aug―29 A Meta-summary and Bioinformatic Analysis Identified Interleukin 6 as a Master Regulator of COVID-19 Severity Biomarkers Mohannad Ghanem, Sharon J Brown, Aysha EAT Mohamed, Heidi R Fuller
33 [GO] 2022―Aug―29 IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden Louise Ziegler, Annika Lundström, Sebastian Havervall, Charlotte Thålin, Bruna Gigante
34 [GO] 2022―Aug―11 The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults Giuseppe Oliveto, Carolina Scagnolari, Federica Frasca, Leonardo Sorrentino, Luigi Matera, Raffaella Nenna, et al. (+10)
35 [GO] 2022―Jul―31 COVID-19 imparted immune manifestation can be combated by NLGP: Lessons from cancer research Anamika Bose, Rathindranath Baral
36 [GO] 2022―Jul―28 Prognostic significance of serum galectin-3 in hospitalized patients with COVID-19 Sevgi Özcan, Esra Dönmez, Sevil Tuğrul Yavuz, Murat Ziyrek, Orhan İnce, H.Suat Küçük, et al. (+5)
37 [GO] 2022―Jul―25 Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators Thalia Medeiros, Gabriel Macedo Costa Guimarães, Fabiana Rabe Carvalho, Lilian Santos Alves, Renan Faustino, Ana Carolina Campi-Azevedo, et al. (+8)
38 [GO] 2022―Jul―22 Is IFN expression by NK cells a hallmark of severe COVID-19? Bárbara Guimarães Csordas, Pedro Henrique de Sousa Palmeira, Rephany Fonseca Peixoto, Fernando Cézar Comberlang Queiroz Davis dos Santos, Isac Almeida de Medeiros, Fátima de Lourdes Assunção Araújo de Azevedo, et al. (+5)
39 [GO] 2022―Jul―18 Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals Clio P. Mavragani, Charalampos Skarlis, Ioannis V. Kostopoulos, Eirini Maratou, Paraskevi Moutsatsou, Evangelos Terpos, et al. (+3)
40 [GO] 2022―Jul―02 Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality Iraj Ahmadi, Alireza Afifipour, Fatemeh Sakhaee, Mohammad Saber Zamani, Fahimeh Mirzaei Gheinari, Enayat Anvari, Abolfazl Fateh
41 [GO] 2022―Jun―07 Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: From prognostic marker to therapeutic agent Jozefien Declercq, Elisabeth De Leeuw, Bart N. Lambrecht
42 [GO] 2022―Apr―25 Cytokine response over the course of COVID-19 infection in pregnant women Daniel B. Rosen, Elisabeth A. Murphy, Ron S. Gejman, Allyson Capili, Rachel L. Friedlander, Sophie Rand, et al. (+8)
43 [GO] 2022―Apr―19 Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population Sara Falahi, Mohammad Hossein Zamanian, Parisa Feizollahi, Alireza Rezaiemanesh, Farhad Salari, Zahra Mahmoudi, Ali Gorgin Karaji
44 [GO] 2022―Apr―05 SARS-CoV-2 triggering autoimmune diseases Leila Mobasheri, Mohammad Hossein Nasirpour, Elham Masoumi, Afsaneh Foolady Azarnaminy, Mozhdeh Jafari, Seyed-Alireza Esmaeili
45 [GO] 2022―Apr―04 Up-regulated Serum Levels of Interleukin (IL)-17A and IL-22 in Egyptian Pediatric Patients with COVID-19 and MIS-C: Relation to the Disease Outcome Gehan Ahmed Mostafa, Hanan Mohamed Ibrahim, Abeer Al Sayed Shehab, Sondos Mohamed Magdy, Nada AboAbdoun Soliman, Dalia Fathy El-Sherif
46 [GO] 2022―Mar―28 Clinical monitored in subjects metabolically healthy and unhealthy before and during a SARS-CoV-2 infection- A cross-sectional study in Mexican population Samuel Treviño, Steffany Cortezano-Esteban, Hugo Hernández-Fragoso, Alfonso Díaz, Rubén Vázquez-Roque, Victor Enrique Sarmiento-Ortega, et al. (+3)
47 [GO] 2022―Mar―04 Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients Mohammadarian Akbari, Mehdi Akhavan-Bahabadi, Navid Shafigh, Afshin Taheriazam, Bashdar Mahmud Hussen, Arezou Sayad, et al. (+4)
48 [GO] 2022―Feb―10 SARS-CoV-2 infection causes intestinal cell damage: Role of interferon’s imbalance Stefany Guimarães Sousa, Antônio Kleiton de Sousa, Cynthia Maria Carvalho Pereira, Anna Sofia Miranda Loiola Araújo, Diva de Aguiar Magalhães, Tarcisio Vieira de Brito, André Luiz dos Reis Barbosa
49 [GO] 2022―Feb―01 Hemoperfusion during veno-venous ECMO in severe COVID-19 with IL-6 elevation Giovanni Giordano, Francesco Alessandri, Francesco Pugliese
50 [GO] 2022―Jan―31 Elevated plasma levels of CXCL16 in severe COVID-19 patients Sandra P. Smieszek, Vasilios M. Polymeropoulos, Christos M. Polymeropoulos, Bartlomiej P. Przychodzen, Gunther Birznieks, Mihael H. Polymeropoulos
51 [GO] 2022―Jan―18 Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis Laura Bergantini, Miriana d'Alessandro, Paolo Cameli, Ambra Otranto, Simona Luzzi, Francesco Bianchi, Elena Bargagli
52 [GO] 2021―Dec―25 Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients S. Ashrafzadeh-Kian, M.R. Campbell, J.C. Jara Aguirre, J. Walsh, A. Kumanovics, G. Jenkinson, et al. (+3)
53 [GO] 2021―Dec―14 Effect of SARS-CoV-2 seropositivity on antigen - specific cytokine and chemokine responses in latent tuberculosis Anuradha Rajamanickam, Nathella Pavan Kumar, Padmapriyadarsini Chandrasekaran, Arul Nancy, P.K. Bhavani, Nandhini Selvaraj, et al. (+7)
54 [GO] 2021―Nov―06 In-vitro cytokine production and nasopharyngeal microbiota composition in the early stage of COVID-19 infection Mehmet Hursitoglu, Nilgun Isıksacan, Betul Erismis, Faruk Karandere, Alev Kural, A.Baki Kumbasar, Kadriye Kart Yasar
55 [GO] 2021―Nov―06 Association and predictive value of biomarkers with severe outcomes in hospitalized patients with sars-cov-2 infection Rafael Fernandez-Botran, Stephen Furmanek, Raghava Sekhar Ambadapoodi, Evelyn Expósito González, Meredith Cahill, Ruth Carrico, et al. (+2)
56 [GO] 2021―Oct―29 Corrigendum to “Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients” [Cytokine 148 (2021) 155662] Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vasilios M. Polymeropoulos, Bushra A. Mina, Christos M. Polymeropoulos, Mihael H. Polymeropoulos
57 [GO] 2021―Oct―06 Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: a prospective observational study Elena Sancho Ferrando, Katja Hanslin, Michael Hultström, Anders Larsson, Robert Frithiof, Miklos Lipcsey
58 [GO] 2021―Oct―06 IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? Chia Siang Kow, Abdullah Faiz Zaihan, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
59 [GO] 2021―Sep―27 Randomized trial drug controlled compendious transcriptome analysis supporting broad and phase specific therapeutic potential of multiple candidates in COVID-19 Abhay Sharma
60 [GO] 2021―Sep―09 Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19) Aeshah A. Ahmed, Ali H. Ad'hiah
61 [GO] 2021―Sep―03 SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3 Wenwen Zhang, Zhenling Ma, Yaru Wu, Xixi Shi, Yanyan Zhang, Min Zhang, et al. (+3)
62 [GO] 2021―Aug―06 COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us? Claudio G. Gallo, Sirio Fiorino, Giovanni Posabella, Donato Antonacci, Antonio Tropeano, Emanuele Pausini, et al. (+9)
63 [GO] 2021―Jul―29 Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’ Sandra P. Smieszek, Bartlomiej P. Przychodzen, Vasilios Polymeropoulos, Christos Polymeropoulos, Mihael H. Polymeropoulos
64 [GO] 2021―Jul―03 Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study Sergey N. Avdeev, Natalia V. Trushenko, Natalia A. Tsareva, Andrey I. Yaroshetskiy, Zamira M. Merzhoeva, Galia S. Nuralieva, et al. (+5)
65 [GO] 2021―Jul―03 Clinical Applications of Thrombopoietin Silencing: A Possible Therapeutic Role in COVID-19? Vincent J. Alentado, Alison R. Moliterno, Edward F. Srour, Melissa A. Kacena
66 [GO] 2021―Jul―03 Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease Nataša Todorović-Raković, Jonathan R. Whitfield
67 [GO] 2021―Jun―07 Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19 Takehiro Hasegawa, Atsushi Nakagawa, Kohjin Suzuki, Kazuto Yamashita, Saya Yamashita, Niina Iwanaga, et al. (+3)
68 [GO] 2021―May―26 The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Gerwyn Morris, Chiara C Bortolasci, Basant K Puri, Wolfgang Marx, Adrienne O'Neil, Eugene Athan, et al. (+5)
69 [GO] 2021―May―24 Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients A. Gradin, H. Andersson, T. Luther, S. Bülow Anderberg, S. Rubertsson, M. Lipcsey, et al. (+4)
70 [GO] 2021―Apr―19 Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19 Jie Geng, Feng Wang, Zhiwei Huang, Xiaobo Chen, Yuliang Wang
71 [GO] 2021―Apr―19 Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico Azalia Avila-Nava, Arturo Cortes-Telles, Darwin Torres- Erazo, Stephanie López-Romero, Rodolfo Chim Aké, Ana Ligia Gutiérrez Solis
72 [GO] 2021―Apr―01 Aberrant Cytokine Expression in COVID-19 Patients: Associations between Cytokines and Disease Severity Yueting Tang, Jiayu Sun, Huaqin Pan, Fen Yao, Yumeng Yuan, Mi Zeng, et al. (+12)
73 [GO] 2021―Mar―27 IL-6 and IL-10 are associated with disease severity and a higher comorbidity in adults with COVID-19 Rafael Luís Luporini, Joice M. de A. Rodolpho, Lauro Tatsuo Kubota, Ana Carolina Baptista Moreno Martin, Marcia R. Cominetti, Fernanda de Freitas Anibal, Henrique Pott-Junior
74 [GO] 2021―Mar―26 Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019 Hao Chen, Rundong Qin, Zhifeng Huang, Wenting Luo, Peiyan Zheng, Huimin Huang, et al. (+3)
75 [GO] 2021―Mar―20 Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019 Guo-Lin Wang, Hui-Xia Gao, Yu-Ling Wang, Xiao Wei, Yu-Zhen Liu, Jian-Hua Lu, et al. (+10)
76 [GO] 2021―Mar―14 Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication Pruthvi Gowda, Shruti Patrick, Shanker Datt Joshi, Rajesh Kumar Kumawat, Ellora Sen
77 [GO] 2021―Mar―07 The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19 Kristina Schönfelder, Katharina Breuckmann, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, et al. (+8)
78 [GO] 2021―Feb―23 Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: a review Benjamin M. Liu, Thomas B Martins, Lisa K. Peterson, Harry R. Hill
79 [GO] 2021―Feb―03 “The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction” Luca Giovanni Locatello, Chiara Bruno, Giandomenico Maggiore, Maria Cilona, Pietro Orlando, Giuseppe Fancello, et al. (+5)
80 [GO] 2021―Jan―28 Prognostic bioindicators in severe COVID-19 patients L. Bergantini, E. Bargagli, M. d'Alessandro, R.M. Refini, P. Cameli, L. Galasso, et al. (+9)
81 [GO] 2021―Jan―18 Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? Ramin Sami, Farshid Fathi, Nahid Eskandari, Meysam Ahmadi, Reza ArefNezhad, Hossein Motedayyen
82 [GO] 2021―Jan―18 Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19 Wafa Sayah, Ismahane Berkane, Imène Guermache, Mohamed Sabri, Fatma Zahra Lakhal, Sarah Yasmine Rahali, et al. (+19)
83 [GO] 2021―Jan―18 The Impact of COVID-19 Infection On The Cytokine Profile of Pregnant Women: A Prospective Case-Control Study Atakan Tanacan, Nuray Yazihan, Seyit Ahmet Erol, Ali Taner Anuk, Fatma Didem Yucel Yetiskin, Derya Biriken, et al. (+4)
84 [GO] 2021―Jan―18 Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia Luca Quartuccio, Martina Fabris, Arianna Sonaglia, Maddalena Peghin, Rossana Domenis, Adriana Cifé, et al. (+2)
85 [GO] 2021―Jan―18 ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? Carolina Scagnolari, Camilla Bitossi, Agnese Viscido, Federica Frasca, Giuseppe Oliveto, Mirko Scordio, et al. (+8)
86 [GO] 2020―Dec―16 Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients Sara Bülow Anderberg, Tomas Luther, Malin Berglund, Rolf Larsson, Sten Rubertsson, Miklos Lipcsey, et al. (+3)
87 [GO] 2020―Dec―15 Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19 Allen Widysanto, Andree Kurniawan, Nata Pratama Hardjo Lugito, Mira Yuniarti, Catherine Gunawan, Jessica Wiryanto, Tasya Meidy Pradhana
88 [GO] 2020―Dec―11 Cytokine Storm Induced by SARS-CoV-2 Infection: The Spectrum of its Neurological Manifestations Parisorn Thepmankorn, John Bach, Ahmed Lasfar, Xilin Zhao, Sami Souayah, Zhao Zhong Chong, Nizar Souayah
89 [GO] 2020―Dec―09 A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19 Lelia Wagner, Walter E. Haefeli, Uta Merle, Hanns-Martin Lorenz, Nicolas Hohmann, Johanna Weiss, Dirk Theile
90 [GO] 2020―Nov―09 An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis Yili Liu, Daihong Chen, Junjie Hou, Haicong Li, Dan Cao, Mingquan Guo, et al. (+5)
91 [GO] 2020―Oct―23 The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19 Juan Gómez, Guillermo M. Albaiceta, Elías Cuesta-Llavona, Marta García-Clemente, Carlos López-Larrea, Laura Amado-Rodríguez, et al. (+9)
92 [GO] 2020―Oct―12 Probable Positive Effects of the Photobiomodulation as an Adjunctive Treatment in COVID-19: A Systematic Review Marzieh Nejatifard, Sohrab Asefi, Raika Jamali, Michael R. Hamblin, Reza Fekrazad
93 [GO] 2020―Sep―30 Cytokine Profile and Disease Severity in Patients with COVID-19 Ali Ghazavi, Ali Ganji, Nafiseh Keshavarzian, Somayeh Rabiemajd, Ghasem Mosayebi
94 [GO] 2020―Sep―29 Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19 Hasan Satış, Hasan Selçuk Özger, Pınar Aysert Yıldız, Kenan Hızel, Özlem Gulbahar, Gonca Erbaş, et al. (+5)
95 [GO] 2020―Aug―20 ADE and hyperinflammation in SARS-CoV2 infection- Comparison with dengue hemorrhagic fever and feline infectious peritonitis Maryse Cloutier, Madhuparna Nandi, Awais Ullah Ihsan, Hugues Allard Chamard, Subburaj Ilangumaran, Sheela Ramanathan
96 [GO] 2020―Aug―15 A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases Abdullah Mahmud-Al-Rafat, Md. Muzammal Haque Asim, Andrew W. Taylor-Robinson, Apurba Majumder, Abdul Muktadir, Hasneen Muktadir, et al. (+4)
97 [GO] 2020―May―30 COVID-19 cytokine storm: The anger of inflammation Mehdi Mahmudpour, Jamshid Roozbeh, Mohsen Keshavarz, Shokrollah Farrokhi, Iraj Nabipour
98 [GO] 2020―May―21 Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions Rezvan Noroozi, Wojciech Branicki, Krzysztof Pyrc, Paweł P. Łabaj, Ewelina Pospiech, Mohammad Taheri, Soudeh Ghafouri-Fard
 [1] 

98 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec